STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[NT 10-Q] AIBOTICS, INC. SEC Filing

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
NT 10-Q
Rhea-AI Filing Summary

Aibotics Inc. (AIBT) filed a Form 12b-25 (NT 10-Q) for the quarter ended September 30, 2025, notifying a late quarterly report. The company cites the need for additional time for auditor review. Under Rule 12b-25(b), it expects to file the Form 10-Q on or before the fifth calendar day following the prescribed due date. The notice lists Jonathan Leinwand as the contact and is signed by CEO and CFO Ben Kaplan.

Positive
  • None.
Negative
  • None.

Insights

Administrative late filing; short grace period under Rule 12b-25.

Aibotics submitted an NT 10-Q, indicating its Q3 2025 report is delayed due to additional auditor review. Rule 12b-25(b) provides a brief extension when timely filing would require unreasonable effort or expense.

The company states it will file the 10-Q within five calendar days of the original due date. The filing is procedural; any operational or financial impacts would depend on the forthcoming 10-Q.


 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

 

 

 

Washington, D.C.  20549

 

 

 

 

 

FORM 12b-25

 

 

 

 

 

 

 

 

NOTIFICATION OF LATE FILING

 

 

 

 

 

 

 

 

(Check One):

oForm 10-K

o Form 20-F

o Form 11-K  

x Form 10-Q

o Form 10-D

o Form N-CEN

o Form N-CSR

 

For Period Ended:   September 30, 2025

o Transition Report on Form 10-K

o Transition Report on Form 20-F

o Transition Report on Form 11-K

o Transition Report on Form 10-Q

For the Transition Period Ended: _____________________________________________________________

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

 

PART I REGISTRANT INFORMATION

Aibotics, Inc.

Full Name of Registrant

 

Former Name if Applicable

100 SE 2nd Street, Suite 2000

Address of Principal Executive Office (Street and Number)

Miami, FL 33131

City, State and Zip Code

 

PART II RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

 

(a)

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

x

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.




PART III NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.)

 

We were unable to file our quarterly report on Form 10-Q for the quarter ended September 30, 2025, within the prescribed period as the Company required additional time for auditor review.

 

PART IV OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

Jonathan Leinwand

 

954

 

903-7856

(Name)

 

(Area Code)

 

(Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). 

 

x Yes

¨ No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? 

 

¨Yes

x No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

 

Aibotics Inc.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date:

November 14, 2025

By

/s/ Ben Kaplan

 

 

 

Ben Kaplan, President

 

 

 

Chief Executive Officer
(Principal Executive Officer

 

 

 

and Principal Financial Officer)


FAQ

What did Aibotics (AIBT) file?

Aibotics filed a Form 12b-25 (NT 10-Q) to notify a late quarterly report.

Which period does the NT 10-Q cover for AIBT?

It covers the quarter ended September 30, 2025.

Why was AIBT’s 10-Q delayed?

The company required additional time for auditor review.

When does AIBT expect to file the 10-Q?

It expects to file on or before the fifth calendar day after the prescribed due date under Rule 12b-25(b).

Who signed AIBT’s notification?

Ben Kaplan, President and Chief Executive Officer (also Principal Financial Officer).

Who is the contact listed in the notice?

Jonathan Leinwand at 954-903-7856.
AIBotics

OTC:AIBT

AIBT Rankings

AIBT Latest News

AIBT Latest SEC Filings

AIBT Stock Data

575.71k
75.84M
60.48%
Biotechnology
Healthcare
Link
United States
Miami